How much funding has Jade Biosciences raised?

Jade Biosciences has raised $380.0M in total funding, most recently a Corporate Round.

Who are Jade Biosciences's investors?

Jade Biosciences's investors include Fairmount, Venrock.

When was Jade Biosciences founded?

Jade Biosciences was founded in 2024.

Where is Jade Biosciences headquartered?

Jade Biosciences is headquartered in Waltham, Massachusetts, United States.

What industry is Jade Biosciences in?

Jade Biosciences operates in Biotech, Healthcare.

How many employees does Jade Biosciences have?

Jade Biosciences has 11-50 employees.

Jade Biosciences

Acquired

On a mission to transform the future of autoimmune care.

Public · Waltham, United States · Founded 2024 · $380.0M raised

Biotech

Healthcare

Headquarters: Waltham, Massachusetts
Employees: 11–50
Founded: 2024
Business Model: B2B
Website: jadebiosciences.com

Total Funding: $380.0M
Last Round: $300.0M Corporate RoundApr 2025
Rounds: 2
Type: Public

About

Jade Biosciences is a clinical-stage biotechnology company founded in 2024 and headquartered in Waltham, Massachusetts, focused on developing best-in-class antibody-based therapies for patients with autoimmune diseases. Its lead program, JADE101, targets inflammation and immunology indications with high unmet need. The company launched with $80M in financing led by Fairmount and Venrock Healthcare Capital Partners.

Summary

Jade Biosciences is a Biotech company based in Waltham, United States, founded in 2024. It has raised $380.0M in total across 2 rounds, most recently a $300.0M Corporate Round round in Apr 2025. Investors include Fairmount and Venrock.